Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
13.3 USD | +0.11% | -7.58% | +15.77% |
30/04 | Alvotech to Manufacture Humira Biosimilar for Quallent Pharmaceuticals | MT |
30/04 | Alvotech to Make Humira Biosimilar Adalimumab-ryvk for Quallent | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+15.77% | 371.54Cr | |
+29.65% | 4.82TCr | |
-0.57% | 4.17TCr | |
+42.66% | 4.1TCr | |
-5.26% | 2.88TCr | |
+10.13% | 2.56TCr | |
-22.61% | 1.9TCr | |
+9.07% | 1.29TCr | |
+29.25% | 1.2TCr | |
-1.82% | 1.18TCr |
- Stock Market
- Equities
- ALVO Stock
- News Alvotech
- Transcript : Alvotech, 2023 Earnings Call, Mar 21, 2024